-5%
Vericiguat stimulates soluble guanylate cyclase (sGC), which promotes relaxation of blood vessels, enhances blood flow, and lowers the workload on the heart—benefiting patients with chronic heart failure.
Verquv 5 is a heart failure medicine containing Vericiguat, a soluble guanylate cyclase (sGC) stimulator. It is prescribed for adults with chronic heart failure who have recently been hospitalized or needed intravenous (IV) treatment and have a reduced ejection fraction (<45%). It helps lower the risk of death and repeated hospitalizations by improving heart and blood vessel function.